BlackRock Institutional Trust’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

BlackRock Institutional Trust’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$481K	Buy	1,375 +24	+2%	+$8.79K	﹤0.01%	3470
2016 Q3	$543K	Buy	1,351 +112	+9%	+$57.2K	﹤0.01%	3469
2016 Q2	$737K	Buy	1,239 +721	+139%	+$438K	﹤0.01%	3413
2016 Q1	$261K	Hold	518	–	–	﹤0.01%	3575
2015 Q4	$343K	Hold	518	–	–	﹤0.01%	3568
2015 Q3	$245K	Hold	518	–	–	﹤0.01%	3616
2015 Q2	$294K	Buy	518 +280	+118%	+$775K	﹤0.01%	3584
2015 Q1	$2.03M	Buy	238 +197	+480%	+$1.72M	﹤0.01%	3107
2014 Q4	$364K	Hold	41	–	–	﹤0.01%	3553
2014 Q3	$195K	Sell	41 -25	-38%	-$132K	﹤0.01%	3610
2014 Q2	$474K	Sell	66 -126	-66%	-$630K	﹤0.01%	3581
2014 Q1	$1.03M	Buy	+192	New	+$907K	﹤0.01%	3405

Other funds holding EIGR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust's EIGR Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Eiger BioPharmaceuticals, Inc. (EIGR) stake by 1.8% in Q4 2016, buying an estimated $8.79K and bringing the position to 1,375 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #3470.

BlackRock Institutional Trust first reported a position in EIGR in Q1 2014 and has held it in 12 quarters since. The position peaked at $2.03M in Q1 2015. 51 funds tracked by Wall St. Rank hold EIGR as of Q4 2016.

BlackRock Institutional Trust held 1,375 shares of Eiger BioPharmaceuticals, Inc. worth $481K as of Q4 2016.
BlackRock Institutional Trust bought 24 Eiger BioPharmaceuticals, Inc. shares in Q4 2016, an estimated $8.79K.
Eiger BioPharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3470 holding.
BlackRock Institutional Trust first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2014 and has held it in 12 quarters since.
BlackRock Institutional Trust's Eiger BioPharmaceuticals, Inc. position peaked at $2.03M in Q1 2015.
51 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.